Skip to main content

Table 1 Demographical characteristics

From: In vivo assessment of neuroinflammation in progressive multiple sclerosis: a proof of concept study with [18F]DPA714 PET

  Patients (n = 8) Healthy controls (n = 7)
Age, mean and SD (years) 53.1 ± 2.7 52.0 ± 4.1
Gender, male/female 3/5 3/4
Genotype, HAB/MAB 4/4 3/4
Subtype MS, PPMS/SPMS 5/3 N/A
Disease duration, mean and SD (years) 13.1 ± 9.4 N/A
EDSS, median and range 5.0 (4.0–6.0) N/A
PASAT-3 score, mean and SD 45.8 ± 10.8 49.6 ± 12.5
SDMT score, mean and SD 44.0 ± 11.9 55.0 ± 13.5
T2 lesion volume, median and range (cm3) 14.3 (3.6–60.6) N/A
  1. Abbreviations: EDSS Expanded Disability Status Scale, HAB genetic high-affinity binder, MAB genetic medium-affinity binder, PASAT Paced Auditory Serial Addition Test, PPMS primary progressive multiple sclerosis, SDMT Symbol Digit Modalities Test, SPMS secondary progressive multiple sclerosis